Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[HIV vaccines].

G Pialoux1, L Slama

  • 1Service des maladies infectieuses et tropicales Hôpital Tenon, Paris. gilles.pialoux@tnn.aphp.fr

Presse Medicale (Paris, France : 1983)
|November 30, 2005
PubMed
Summary
This summary is machine-generated.

Developing a safe, effective, and accessible HIV vaccine is crucial for ending the pandemic, especially in developing nations. Promising vaccine candidates are in clinical trials, offering hope for future prevention.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Detecting quality of life alterations in people living with HIV: Development and evaluation of the OCTAVE® self-questionnaire.

Infectious diseases now·2025
Same author

The burden of secrecy in the management of multimorbidity in older people living with HIV aged 70 and over.

AIDS care·2024
Same author

Proposal of the French HIV Society on the CD4 threshold below which patients living with HIV who wish to be vaccinated against Monkeypox should receive a 3-dose regimen.

Infectious diseases now·2022
Same author

[Recurrent acute fatty liver of pregnancy: About a case and a review of the literature].

Gynecologie, obstetrique, fertilite & senologie·2022
Same author

Why are people still dying of drug-susceptible TB in Paris in the 21<sup>st</sup> century?

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2022
Same author

High performance of a novel antigen detection test on nasopharyngeal specimens for diagnosing SARS-CoV-2 infection.

Journal of medical virology·2021
Same journal

Predictive analytics and risk stratification models in internal medicine: from risk scores to real-time machine learning.

Presse medicale (Paris, France : 1983)·2026
Same journal

Artificial Intelligence in skin disease therapeutics: from drug discovery to personalized treatment pathways.

Presse medicale (Paris, France : 1983)·2026
Same journal

AI in clinical diagnostics in dermatology: applications, validation, and real-world use cases.

Presse medicale (Paris, France : 1983)·2026
Same journal

Artificial Intelligence in medical research and publishing: progress, risks, and future perspectives.

Presse medicale (Paris, France : 1983)·2026
Same journal

Ethical, legal, and regulatory challenges in AI-based healthcare tools.

Presse medicale (Paris, France : 1983)·2026
Same journal

Decision-making for clinicians.

Presse medicale (Paris, France : 1983)·2026
See all related articles

Area of Science:

  • Immunology
  • Vaccinology
  • Virology

Context:

  • The global HIV pandemic necessitates a vaccine for effective control.
  • Developing countries bear the most severe impact of HIV.
  • Significant progress has been made, with approximately 30 HIV vaccine candidates in clinical trials.

Purpose:

  • To summarize the current state of HIV vaccine development.
  • To highlight the scientific challenges and promising strategies in the search for an effective HIV vaccine.

Summary:

  • An ideal HIV vaccine should induce neutralizing antibodies, cytotoxic T lymphocytes (CTL), and potentially mucosal immunity.
  • Key challenges include defining correlates of immunity.
  • Recombinant vector, lipopeptide, and DNA vaccines have shown potential in inducing CTL responses.

Related Experiment Videos

  • Prime-boost strategies are being explored in ongoing clinical trials.

    • Impact:

    • Successful HIV vaccine development could significantly curb the global HIV pandemic.
    • Affordable and accessible vaccines are essential for equitable global health outcomes.
    • Continued research and clinical trials offer hope for a future free from HIV.